EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/02/2025
Back to search
Official data from USPTO
APDC ADVANCED PHARMACEUTICAL DEVELOPMENT CENTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
APDC ADVANCED PHARMACEUTICAL DEVELOPMENT CENTER
ST13
US500000097723397Class
42
Filing
97723397
Registration
7573291
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
05/08/2025
Trademark type
Word
Nice classes
42
Filing date
12/19/2022
Registration date
11/19/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/19/2024
Last transaction
05/08/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/13/2022
First use in commerce
12/12/2022
Drawing code
4
Owner type
03
Owner location
Richmond, VA
Examiner
RITTNER, HANNO
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Phlow Corp.
Representatives
John R. Mills Mills IP Law, PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development
Publications
History of USPTO decisions and trademark events.
36 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/19/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
11/19/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/15/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/15/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
09/18/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/18/2024
IUAF
USE AMENDMENT FILED
07/16/2024
EISU
TEAS STATEMENT OF USE RECEIVED
07/16/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/18/2024
EX2G
SOU EXTENSION 2 GRANTED
06/18/2024
EXT2
SOU EXTENSION 2 FILED
06/18/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/18/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/13/2023
EX1G
SOU EXTENSION 1 GRANTED
12/11/2023
EXT1
SOU EXTENSION 1 FILED
12/11/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/11/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/16/2023
PUBO
PUBLISHED FOR OPPOSITION
05/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/31/2023
GNRT
NON-FINAL ACTION E-MAILED
03/31/2023
CNRT
NON-FINAL ACTION WRITTEN
03/31/2023
DOCK
ASSIGNED TO EXAMINER
03/28/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2023
NWAP
NEW APPLICATION ENTERED
12/22/2022
Continuous trademark protection
Get notified about every new filing that threatens APDC ADVANCED PHARMACEUTICAL DEVELOPMENT CENTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.